Somatic Cells Regulate Maternal mRNA Translation and Developmental Competence of Mouse Oocytes

Nature Cell Biology

Volumn 15, Issue 12, 2013, Pages 1415-1423

  Chen, Jing ^a   Torcia, Simona ^a   Xie, Fang ^a   Lin, Chih Jen ^a   Cakmak, Hakan ^a   Franciosi, Federica ^a   Horner, Kathleen ^a   Onodera, Courtney ^a   Song, Jun S ^a   Cedars, Marcelle I ^a   Ramalho Santos, Miguel ^a   Conti, Marco ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; AREG PROTEIN, MOUSE; CELL CYCLE PROTEIN; EPIDERMAL GROWTH FACTOR DERIVATIVE; GLYCOPROTEIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; MTOR PROTEIN, MOUSE; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE; TPX2 PROTEIN, MOUSE;

129 MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; CUMULUS CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MEIOSIS; METABOLISM; MOUSE; OOCYTE; OOCYTE DEVELOPMENT; PHYSIOLOGY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; ARTICLE;

AMPHIREGULIN; ANIMALS; CELL CYCLE PROTEINS; CELLS, CULTURED; CUMULUS CELLS; EGF FAMILY OF PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEIOSIS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; OOCYTES; OOGENESIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER, STORED; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84890840916     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2873     Document Type: Article

References (48)

1. Spradling, A., Fuller, M. T., Braun, R. E. & Yoshida, S. Germline stem cells. Cold Spring Harb. Perspect. Biol. 3, a002642 (2011).
2. Yoshida, S. Spermatogenic stem cell system in the mouse testis. Cold Spring Harb. Symp. Quant. Biol. 73, 25–32 (2008).
3. Matzuk, M. M., Burns, K. H., Viveiros, M. M. & Eppig, J. J. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 296, 2178–2180 (2002).
4. Gosden, R. & Lee, B. Portrait of an oocyte: our obscure origin. J. Clin. Invest. 120, 973–983 (2010).
5. Chian, R. C., Lim, J. H. & Tan, S. L. State of the art in in-vitro oocyte maturation. Curr. Opin. Obstet. Gynecol. 16, 211–219 (2004).
6. Chang, H. C., Liu, H., Zhang, J., Grifo, J. & Krey, L.C. Developmental incompetency of denuded mouse oocytes undergoing maturation in vitro is ooplasmic in nature and is associated with aberrant Oct-4 expression. Human Reprod. 20, 1958–1968 (2005).
7. Luciano, A. M. et al. Developmental capability of denuded bovine oocyte in a co-culture system with intact cumulus-oocyte complexes: role of cumulus cells, cyclic adenosine 3’, 5’-monophosphate, and glutathione. Mol. Reproduct. Dev. 71, 389–397 (2005).
8. Eppig, J. J. Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. Reprod. Fertil. Dev. 8, 485–489 (1996).
9. Park, J. Y. et al. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 303, 682–684 (2004).
10. Shimada, M., Hernandez-Gonzalez, I., Gonzalez-Robayna, I. & Richards, J. S. Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: key roles for prostaglandin synthase 2 and progesterone receptor. Mol. Endocrinol. 20, 1352–1365 (2006).
11. Hsieh, M. et al. Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol. Cell Biol. 27, 1914–1924 (2007).
12. Panigone, S., Hsieh, M., Fu, M., Persani, L. & Conti, M. Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway. Mol. Endocrinol. 22, 924–936 (2008).
13. Hsieh, M., Thao, K. & Conti, M. Genetic dissection of epidermal growth factor receptor signaling during luteinizing hormone-induced oocyte maturation. PLoS ONE 6, e21574 (2011).
14. Richter, J. D. CPEB: a life in translation. Trends Biochem. Sci. 32, 279–285 (2007).
15. Gruss, O. J. et al. Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells. Nat. Cell Biol. 4, 871–879 (2002).
16. De Luca, M., Lavia, P. & Guarguaglini, G. A functional interplay between Aurora-A, Plk1 and TPX2 at spindle poles: Plk1 controls centrosomal localization of Aurora-A and TPX2 spindle association. Cell Cycle 5, 296–303 (2006).
17. Kufer, T. A. et al. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J. Cell Biol. 158, 617–623 (2002).
18. Chang, H. et al. The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer. Oncol. Rep. 27, 1353–1359 (2012).
19. Ma, Y. et al. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. Clin. Cancer Res. 12, 1121–1127 (2006).
20. Shigeishi, H. et al. Expression of TPX2 in salivary gland carcinomas. Oncol. Rep. 21, 341–344 (2009).
21. Brunet, S. et al. Meiotic regulation of TPX2 protein levels governs cell cycle progression in mouse oocytes. PLoS ONE 3, e3338 (2008).
22. Chen, J. et al. Genome-wide analysis of translation reveals a critical role for deleted in azoospermia-like (Dazl) at the oocyte-to-zygote transition. Genes Dev. 25, 755–766 (2011).
23. Brook, M., Smith, J. W. & Gray, N. K. The DAZL and PABP families: RNA-binding proteins with interrelated roles in translational control in oocytes. Reproduction 137, 595–617 (2009).
24. Conti, M., Hsieh, M., Park, J. Y. & Su, Y. Q. Role of the epidermal growth factor network in ovarian follicles. Mol. Endocrinol. 20, 715–723 (2006).
25. Fan, H. Y. et al. Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicle development and ovulation. Development 135, 2127–2137 (2008).
26. De La Fuente, R., O’Brien, M. J. & Eppig, J. J. Epidermal growth factor enhances preimplantation developmental competence of maturing mouse oocytes. Hum. Reprod. 14, 3060–3068 (1999).
27. Prochazka, R., Kalab, P. & Nagyova, E. Epidermal growth factor-receptor tyrosine kinase activity regulates expansion of porcine oocyte-cumulus cell complexes in vitro. Biol. Reprod. 68, 797–803 (2003).
28. Richani, D., Ritter, L. J., Thompson, J. G. & Gilchrist, R. B. Mode of oocyte maturation affects EGF-like peptide function and oocyte competence. Mol. Hum. Rreprod. 19, 500–509 (2013).
29. Han, S. J. et al. Protein kinase B/Akt phosphorylation of PDE3A and its role in mammalian oocyte maturation. EMBO J. 25, 5716–5725 (2006).
30. Kalous, J. et al. PKB/AKT is involved in resumption of meiosis in mouse oocytes. Biol. Cell 98, 111–123 (2006).
31. Grzmil, M. & Hemmings, B. A. Translation regulation as a therapeutic target in cancer. Cancer Res. 72, 3891–3900 (2012).
32. Jagarlamudi, K. et al. Oocyte-specific deletion of Pten in mice reveals a stage-specific function of PTEN/PI3K signaling in oocytes in controlling follicular activation. PLoS ONE 4, e6186 (2009).
33. Busser, B., Sancey, L., Brambilla, E., Coll, J. L. & Hurbin, A. The multiple of amphiregulin in human cancer. Biochim. Biophys. Acta 1816, 119–131 (2011).
34. Hynes, N. E. & Lane, H. A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5, 341–354 (2005).
35. Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307–318 (2009).
36. Inoki, K., Kim, J. & Guan, K. L. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu. Rev. Pharmacol. Toxicol. 52, 381–400 (2012).
37. Magnuson, B., Ekim, B. & Fingar, D. C. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem. J. 441, 1–21 (2012).
38. Ruggero, D. & Sonenberg, N. The Akt of translational control. Oncogene 24, 7426–7434 (2005).
39. Meyuhas, O. Synthesis of the translational apparatus is regulated at the translational level. Eur. J. Biochem. 267, 6321–6330 (2000).
40. Hsieh, A. C. et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485, 55–61 (2012).
41. Barna, M. et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456, 971–975 (2008).
42. Su, Y. Q. et al. Selective degradation of transcripts during meiotic maturation of mouse oocytes. Dev. Biol. 302, 104–117 (2007).
43. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).
44. Dai, M. et al. Evolving gene/transcriptdefinitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175 (2005).
45. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat. Protoc. 4, 44–57 (2009).
46. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009).
47. P. Machanick & Bailey, T. L. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 2712, 1696–1697 (2011.).
48. Crooks, G. E., Hon, G. & Chandonia, J. M. Brenner SE WebLogo: a sequence logo generator. Genome Res. 14, 1188–1190 (200).